med-c-logo.png

  • Home

  • About Us

    • Company Overview
    • Management Team
    • Board of Directors
    • In the Media
    • Contact Us

  • Pipeline

  • Therapeutics

    • CTCL
    • Actinic Keratosis
    • Squamous & Basal Cell Carcinoma
    • Cutaneous Leishmaniasis

  • More

    https://www.prnewswire.com/news-releases/medc-biopharma-and-sana-healthcare-partner-to-advance-skin-oncology-platform-301205995.html

    https://finance.yahoo.com/news/aro-volcani-centre-collaboration-rabin-184500848.html

    https://www.oncotarget.com/article/27528

    https://pubmed.ncbi.nlm.nih.gov/32284791

    https://www.calcalistech.com/ctech/articles/0

    https://www.civilized.life/articles/canadian-company-develops-cancer-treatment-using-cannabis-based-israeli-technology

    https://en.globes.co.il/en/article-medc-develops-medical-cannabis-skin-cancer-cure-1001267282

    Breakthrough Therapies

    Screenshot_20200627-094742_Chrome.jpg
    Picture12.jpg
    Picture15.jpg
    Picture14.jpg
    Picture13.jpg
    Picture16.jpg

    • Home

    • About Us

      • Company Overview
      • Management Team
      • Board of Directors
      • In the Media
      • Contact Us

    • Pipeline

    • Therapeutics

      • CTCL
      • Actinic Keratosis
      • Squamous & Basal Cell Carcinoma
      • Cutaneous Leishmaniasis

    • More

      avi@medc.bio​

      ©2020 MedCbiopharma. All Rights Reserved. Proudly created by wix_pro

      229 Yonge Street #400
      Toronto, ON M5B 1N9 Canada